Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.
Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study.
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
Boosting CNS axon regeneration by circumventing limitations of natural cytokine signaling.
Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study.
Chronic pain disrupts the reward circuitry in multiple sclerosis.
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells.
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
[The biological role of sulfatides].
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.
A triple-effect cocktail produced by neural stem cells as a novel neurorepair therapy for chronic stage CNS autoimmunity.
Evaluation of Disability Progression as an Endpoint in Clinical Trials for Relapsing-Remitting Multiple Sclerosis (RRMS): Comparison of the Define and Confirm Studies.
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.
Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
Analysis of the Recent HTA Decision Making Landscape for Multiple Sclerosis Therapies - Trends and Future Opportunities.
A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.
Multiple sclerosis: Bigger brains resist disability in MS.
Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.
Pharmacoeconomic Aspects of Multiple Sclerosis Treatments in Iran.
Biochemical manifestations of the nervous tissue degradation after the blood-brain barrier opening or water intoxication in rats.
Caveolin-1 Is Critical for Lymphocyte Trafficking into Central Nervous System during Experimental Autoimmune Encephalomyelitis.
Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability.
Analysis of Expenditure in Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2013 in Spain.
All relapsing multiple sclerosis patients should be managed at a specialist clinic - Commentary.

Pages